Companion Diagnostic Strategies to Accelerate ADC Development: A Case Study on Teliso-V Companion Diagnostics’ Role in ADC Development & Drug Approval
Time: 5:30 pm
day: Scientific Program Day One PM
Details:
- Outlining the role of companion diagnostics in ADC development and approval
- Sharing a case-study on Teliso V, an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
- Assessing a CDX bridging strategy and early planning for RxDx co-approval
